Novo Nordisk Pharmatech is a leading global supplier of high-quality ingredients for the biopharmaceutical and pharmaceutical industries. The company has attracted an extensive roster of leading pharmaceutical companies through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy.

We were established in 1949, acquired by Novo Nordisk in 1986 and have been part of the pharmaceutical group since then. By delivering excellence at every step – through manufacturing and quality control, precision delivery and a comprehensive risk mitigation strategy – we help our customers keep development on track, production flowing and product supplied to hospitals and patients.

Recombinant insulin
We aim to be the best supplier of insulin for cell culture processes by excelling throughout the supply chain – beginning with the quality of our insulin, which is sourced directly from Novo Nordisk, the world’s largest producer.

Quaternary ammonium compounds (Quats)
We provide only the best and safest ingredients for the pharmaceutical and personal care industries. Ingredients produced according to the highest cGMP standards and backed by complete regulatory documentation.

Pharmaceutical

Novo Nordisk Pharmatech A/S

Ulla Grove Krogsgaard Thomsen

Connie Langberg Heinze

Cassandra Farrell

Daniel Heinz Löfgren

Philip Stafford

Christoph Kalthoff

Astrid Burke

Gamze Tombak

Mikkel Mølvig Dalsø

Annette Behrens

Samia Kappe

Martin Lund

Bjarne Vincents

Jonas Hoeg Thygesen

Jay Calbi

Andreas Kyhn Brejnholt

Bo Højriis Frandsen

The Research and Development team at Novo Nordisk Pharmatech A/S is dedicated to innovating and optimizing high-quality ingredients for the biopharmaceutical and pharmaceutical industries. Comprising experts in enzyme science, data analysis, and product development, the team focuses on advancing formulation processes, ensuring compliance with cGMP standards, and enhancing the efficacy and safety of recombinant insulin and quaternary ammonium compounds. Through rigorous scientific research and collaboration, they aim to support the company's mission of delivering excellence and reliability to customers and patients.

Research and Development

Leadership Team

Sales and Marketing

Information Technology

Research and Development

About

Team members

Other teams at Novo Nordisk Pharmatech A/S

Leadership Team

Sales and Marketing

Information Technology